240 related articles for article (PubMed ID: 28748425)
21. Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.
Osmani Z; Schrama TJ; Zacouris-Verweij W; Andersen J; Frankel S; Bultink IEM; Cornet A; van Vollenhoven RF
Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33795484
[TBL] [Abstract][Full Text] [Related]
22. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
[TBL] [Abstract][Full Text] [Related]
23. Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.
Matsuda T; Ly NTM; Kambe N; Nguyen CTH; Ueda-Hayakawa I; Son Y; Okamoto H
J Dermatol; 2018 Mar; 45(3):344-348. PubMed ID: 29239026
[TBL] [Abstract][Full Text] [Related]
24. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
Ahn SJ; Ryu SJ; Joung JY; Lee BR
Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
[TBL] [Abstract][Full Text] [Related]
25. Hydroxychloroquine retinopathy.
Yusuf IH; Sharma S; Luqmani R; Downes SM
Eye (Lond); 2017 Jun; 31(6):828-845. PubMed ID: 28282061
[TBL] [Abstract][Full Text] [Related]
26. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
Martín-Iglesias D; Artaraz J; Fonollosa A; Ugarte A; Arteagabeitia A; Ruiz-Irastorza G
Lupus; 2019 Apr; 28(4):555-559. PubMed ID: 30755141
[TBL] [Abstract][Full Text] [Related]
27. Improving eye screening practice among pediatric rheumatology patients receiving hydroxychloroquine.
AlAhmed O; Way A; Akoghlanian S; Barbar-Smiley F; Lemle S; MacDonald D; Frost E; Wise K; Lee L; Ardoin SP; Sivaraman V
Lupus; 2021 Feb; 30(2):269-279. PubMed ID: 33307983
[TBL] [Abstract][Full Text] [Related]
28. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.
Schmajuk G; Yazdany J; Trupin L; Yelin E
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):386-92. PubMed ID: 20391485
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
Carmichael SJ; Beal J; Day RO; Tett SE
J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
[TBL] [Abstract][Full Text] [Related]
30. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
31. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.
Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S
Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112
[TBL] [Abstract][Full Text] [Related]
32. Curvilinear bodies are associated with adverse effects on muscle function but not with hydroxychloroquine dosing.
Khoo T; Otto S; Smith C; Koszyca B; Lester S; Blumbergs P; Limaye V
Clin Rheumatol; 2017 Mar; 36(3):689-693. PubMed ID: 27629259
[TBL] [Abstract][Full Text] [Related]
33. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.
Carmichael SJ; Day RO; Tett SE
Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis.
Faselis C; Zeng-Treitler Q; Cheng Y; Kerr GS; Nashel DJ; Liappis AP; Weintrob AC; Karasik PE; Arundel C; Boehm D; Heimall MS; Connell LB; Taub DD; Shao Y; Redd DF; Sheriff HM; Zhang S; Fletcher RD; Fonarow GC; Moore HJ; Ahmed A
Arthritis Rheumatol; 2021 Sep; 73(9):1589-1600. PubMed ID: 33973403
[TBL] [Abstract][Full Text] [Related]
35. Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
Feldman CH; Yazdany J; Guan H; Solomon DH; Costenbader KH
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1712-21. PubMed ID: 26097166
[TBL] [Abstract][Full Text] [Related]
36. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
Agarwal P; Wong YH; Dasgupta E; Agarwal R; Livingstone BI; Ramamurthy S; Chyn GS
Cutan Ocul Toxicol; 2015; 34(3):179-84. PubMed ID: 25068998
[TBL] [Abstract][Full Text] [Related]
37. The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
Pedrosa T; Kupa LVK; Pasoto SG; Aikawa NE; Borba EF; Duarte NJ; Leon EP; Silva CA; Bonfá E
Lupus; 2021 Apr; 30(4):554-559. PubMed ID: 33402039
[TBL] [Abstract][Full Text] [Related]
38. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
Wolfe F; Marmor MF
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
[TBL] [Abstract][Full Text] [Related]
39. Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus.
Lee JE; Nam DR; Sung YK; Kim YJ; Jung SY
Sci Rep; 2023 May; 13(1):7270. PubMed ID: 37142639
[TBL] [Abstract][Full Text] [Related]
40. Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity.
Anderson C; Pahk P; Blaha GR; Spindel GP; Alster Y; Rafaeli O; Marx JL
Retina; 2009 Sep; 29(8):1188-92. PubMed ID: 19491724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
